- Home
- FISI vs LRMR Comparison
FISI vs LRMR Comparison
Compare FISI & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FISI | LRMR |
|---|---|---|
| Founded | 1817 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 804.4M | 455.8M |
| IPO Year | 1999 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FISI | LRMR |
|---|---|---|
| Price | $39.19 | $3.06 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $45.00 | $14.40 |
| AVG Volume (30 Days) | 96.8K | ★ 1.3M |
| Earning Date | 10-22-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.28% | N/A |
| EPS Growth | ★ 231.27 | N/A |
| EPS | ★ 2.08 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.51 | N/A |
| Revenue Next Year | $4.63 | N/A |
| P/E Ratio | $18.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.61 | $2.72 |
| 52 Week High | $42.97 | $6.42 |
Technical Indicators
Market Signals| Indicator | FISI | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 33.73 | 33.64 |
| Support Level | $37.78 | $3.02 |
| Resistance Level | $40.33 | $3.76 |
| Average True Range (ATR) | 0.67 | 0.20 |
| MACD | -0.19 | -0.07 |
| Stochastic Oscillator | 1.80 | 15.36 |
Price Performance
Historical ComparisonAbout FISI Financial Institutions Inc.
Financial Institutions Inc operates through its subsidiaries, providing full range of banking services to consumer, commercial and municipal customers in Western and Central New York, and commercial loans in the Mid-Atlantic region, through a loan production office in Ellicott City, Maryland. It offers a broad range of loans including commercial business and revolving lines of credit, commercial mortgages, equipment loans, residential mortgage loans and home equity loans and lines of credit, automobile loans and personal loans. It operates in single segment of Banking.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.